Department of Pediatric Medicine, Hematology-Oncology
Texas Children's Hospital
1102 Bates St.Suite 1570Houston, TX 77030Get Map & Directions
Executive Vice Chair, Department of Pediatrics - Baylor College of MedicineDeputy Director, Texas Children's Cancer and Hematology CentersMartha Ann and Harold M. Selzman, M.D. Endowed Chair, Institute for Clinical and Translational Research, Baylor College of MedicineVice President, Clinical and Translational Research, Baylor College of MedicineCo-Director, Developmental Therapeutics Program, Texas Children's Cancer CenterProfessor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Medical College of Ohio at Toledo, Doctor of Medicine, 1984
Albany Medical College, Pediatrics, 1985
Letterman Army Medical Center, Pediatrics, 1987
Walter Reed Army Medical Center, Pediatric Hematology Oncology, 1990
Dr. Susan Blaney is the Deputy Director of the Texas Children’s Cancer and Hematology Centers; Executive Vice Chair, Department of Pediatrics, Baylor College of Medicine (BCM); Vice President, Clinical and Translational Research, BCM; and holds the Martha Ann and Harold M. Selzman, M.D. Endowed Chair in the Institute for Clinical and Translational Research at BCM. She is also the Vice Chair of the Children’s Oncology Group, the National Cancer Institute (NCI) supported clinical trials group and the world’s largest organization devoted exclusively to pediatric cancer research.
Dr. Blaney serves as the Co-Director of the Developmental Therapeutics Program at Texas Children’s Cancer Center where she performs pre-clinical and clinical studies of new antineoplastic agents. A primary focus of her research is the development of new drugs for the treatment of central nervous system tumors in children with a particular emphasis on the development of new agents for intrathecal administration.
For more information, visit Dr. Susan Blaney’s profile on VIICTR.
PharmacologyNew Drug DevelopmentNeuro-Oncology
Pre-clinical and clinical studies of new antineoplastic agentsDevelopmental TherapeuticsCentral nervous system tumorsNew agents for intrathecal administration
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.